rs57878668

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_005055.5(RAPSN):​c.241T>C​(p.Phe81Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00569 in 1,613,790 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 47 hom., cov: 32)
Exomes 𝑓: 0.0045 ( 84 hom. )

Consequence

RAPSN
NM_005055.5 missense

Scores

2
1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 6.92

Publications

7 publications found
Variant links:
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
RAPSN Gene-Disease associations (from GenCC):
  • fetal akinesia deformation sequence 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • neuromuscular disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • congenital myasthenic syndrome 11
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_005055.5
BP4
Computational evidence support a benign effect (MetaRNN=0.006080568).
BP6
Variant 11-47448102-A-G is Benign according to our data. Variant chr11-47448102-A-G is described in ClinVar as Benign. ClinVar VariationId is 235304.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0173 (2625/152168) while in subpopulation AFR AF = 0.0481 (1996/41500). AF 95% confidence interval is 0.0463. There are 47 homozygotes in GnomAd4. There are 1290 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005055.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAPSN
NM_005055.5
MANE Select
c.241T>Cp.Phe81Leu
missense
Exon 2 of 8NP_005046.2
RAPSN
NM_001440490.1
c.241T>Cp.Phe81Leu
missense
Exon 2 of 8NP_001427419.1
RAPSN
NM_001440491.1
c.241T>Cp.Phe81Leu
missense
Exon 2 of 8NP_001427420.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAPSN
ENST00000298854.7
TSL:1 MANE Select
c.241T>Cp.Phe81Leu
missense
Exon 2 of 8ENSP00000298854.2
RAPSN
ENST00000352508.7
TSL:1
c.241T>Cp.Phe81Leu
missense
Exon 2 of 6ENSP00000298853.3
RAPSN
ENST00000529341.1
TSL:1
c.241T>Cp.Phe81Leu
missense
Exon 2 of 5ENSP00000431732.1

Frequencies

GnomAD3 genomes
AF:
0.0172
AC:
2621
AN:
152050
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0481
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00511
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0149
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00518
Gnomad OTH
AF:
0.0106
GnomAD2 exomes
AF:
0.00786
AC:
1969
AN:
250414
AF XY:
0.00686
show subpopulations
Gnomad AFR exome
AF:
0.0499
Gnomad AMR exome
AF:
0.00382
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0133
Gnomad NFE exome
AF:
0.00575
Gnomad OTH exome
AF:
0.00670
GnomAD4 exome
AF:
0.00448
AC:
6552
AN:
1461622
Hom.:
84
Cov.:
36
AF XY:
0.00437
AC XY:
3179
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.0491
AC:
1645
AN:
33480
American (AMR)
AF:
0.00396
AC:
177
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00310
AC:
81
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000719
AC:
62
AN:
86258
European-Finnish (FIN)
AF:
0.0128
AC:
683
AN:
53168
Middle Eastern (MID)
AF:
0.00936
AC:
54
AN:
5768
European-Non Finnish (NFE)
AF:
0.00311
AC:
3456
AN:
1111996
Other (OTH)
AF:
0.00651
AC:
393
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
417
835
1252
1670
2087
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0173
AC:
2625
AN:
152168
Hom.:
47
Cov.:
32
AF XY:
0.0173
AC XY:
1290
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0481
AC:
1996
AN:
41500
American (AMR)
AF:
0.00510
AC:
78
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.0149
AC:
158
AN:
10606
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00518
AC:
352
AN:
67984
Other (OTH)
AF:
0.0104
AC:
22
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
125
251
376
502
627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00770
Hom.:
39
Bravo
AF:
0.0173
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.0518
AC:
228
ESP6500EA
AF:
0.00407
AC:
35
ExAC
AF:
0.00912
AC:
1107
Asia WGS
AF:
0.00144
AC:
6
AN:
3478
EpiCase
AF:
0.00474
EpiControl
AF:
0.00379

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Nov 30, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

May 11, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Jan 06, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Fetal akinesia deformation sequence 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myasthenic syndrome Benign:1
Jan 13, 2021
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Congenital myasthenic syndrome 11 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.046
T
Eigen
Benign
-0.19
Eigen_PC
Benign
0.015
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.69
N
PhyloP100
6.9
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.072
Sift
Benign
0.48
T
Sift4G
Benign
0.51
T
Polyphen
0.0030
B
Vest4
0.24
MutPred
0.14
Loss of helix (P = 0.1299)
MVP
0.78
MPC
0.18
ClinPred
0.015
T
GERP RS
4.8
Varity_R
0.16
gMVP
0.37
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57878668; hg19: chr11-47469654; API